•  
  •  
 

Document Type

Original Article

Abstract

Background: The removal of the uterus by surgical procedures is the standard treatment for endometrial cancer, which is the most common type of malignant gynecological tumor. Surgery for early-stage endometrial cancer often involves a total abdominal hysterectomy and bilateral salpingo-oophorectomy, with or without bilateral pelvic/para-aortic lymphadenectomy. In some cases, the patient may also have bilateral pelvic lymphadenectomy. Aim and objectives: The objective of the study is to evaluate the efficacy of radical hysterectomy with or without pelvic lymphadenectomy in the treatment of stage II endometrial cancer. Both approaches were examined in terms of the adverse effects they produced, as well as their success and relapse rates. Subjects and methods: Forty patients undergoing radical hysterectomy for stage II endometrial cancer at Al-Azhar University Hospitals were included in this prospective study. Result: In terms of age, parity, and BMI, neither group differed significantly from the other (P value > 0.05). At a 12-month follow-up, women whose treatment included pelvic lymphadenectomy had a significantly higher rate of recurrence and a significantly poorer survival rate than those whose treatment did not. However, at 12 months of follow-up, there was no statistically significant difference among women who had pelvic lymphadenectomy and those who did not (P > 0.05) in terms of complications. Conclusion: At 12 months follow-up, women who had a pelvic lymphadenectomy had a significantly higher rate of recurrence and a significantly lower survival rate than women who did not.

Keywords

radical hysterectomy; pelvic lymphadenectomy; stage II endometrial carcinoma.

Subject Area

Onco-surgery

Download

Share

COinS